KeyBanc Capital has published its current ranking of preferred names within the healthcare sector, placing Elanco Animal Health at the top of its list. The firm’s selections cover five businesses that operate across different subsectors of healthcare finance and delivery - from veterinary pharmaceuticals to employer fertility benefits.
How the list is composed
KeyBanc’s top five spans a range of business models: animal health products, digital therapeutics for musculoskeletal conditions, consumer-facing beauty and wellness technology, medication management automation for hospitals and pharmacies, and employer-focused fertility benefits administration. Each pick is accompanied by recent corporate developments and noted analyst activity.
1. Elanco Animal Health (ELAN)
Elanco ranks first in KeyBanc’s healthcare lineup. The company develops and markets products for companion animals and food animals, operating across both segments of the animal health market. Elanco reported a fourth-quarter beat on both revenue and earnings, prompting KeyBanc to lift its price target. In addition, UBS and Stifel have reaffirmed Buy ratings on the shares.
2. Hinge Health (HNGE)
Hinge Health occupies the second slot. The company provides digital musculoskeletal care, delivering virtual physical therapy and exercise therapy programs aimed at chronic pain and orthopedic conditions. Recent corporate news includes the appointment of Tyler Sloat, the CFO of Freshworks, to Hinge Health’s board of directors. Analyst coverage has been mixed, with RBC raising its price target while Barclays trimmed its target.
3. Oddity Tech (ODD)
Placed third on KeyBanc’s list, Oddity Tech operates in the technology-driven beauty and wellness space, using data science and artificial intelligence to develop consumer products. The company’s board has approved a $200 million share repurchase program. At the same time, several analysts have moved to downgrade the stock and cut price targets; among those firms taking action were BofA Securities and Barclays, which cited disruption tied to a major advertising partner.
4. Omnicell (OMCL)
Omnicell is fourth on the ranking and is known for medication management automation solutions intended to improve pharmacy operations and support patient safety. In its fourth-quarter 2025 earnings report, Omnicell missed earnings-per-share expectations while modestly exceeding revenue forecasts.
5. Progyny (PGNY)
Rounding out the list, Progyny provides managed fertility and family building benefits aimed at employers seeking comprehensive reproductive health coverage for employees. The company issued fiscal 2026 guidance that came in below Wall Street expectations and adjusted its year-end member count; those developments prompted multiple firms, including Jefferies and BTIG, to lower their price targets on the stock.
Sectoral scope and implications
KeyBanc’s selections illustrate the diversity within ‘‘healthcare’’ as an investment category, encompassing pet and livestock therapeutics, virtual care platforms, consumer-facing wellness tech, clinical automation, and benefits administration. The list includes established providers of infrastructure and newer entrants leveraging data and platform models.
Each company cited on the list has a clear corporate event or analyst reaction noted by KeyBanc - earnings results and target changes for Elanco and Omnicell, governance and analyst target movements for Hinge Health, a buyback and downgrade activity for Oddity Tech, and guidance and member assumptions that influenced sentiment toward Progyny.
Summary
KeyBanc’s top five healthcare picks are Elanco Animal Health, Hinge Health, Oddity Tech, Omnicell and Progyny. The selections reflect a cross-section of subindustries within healthcare and are accompanied by recent company-specific developments and analyst responses that have shaped market sentiment.